AstraZenecas proposed acquisition of Alexion Pharmaceuticals, Inc.has achieved an important step towards completion by having cleared the European Commission review.
The clearance follows competition clearances in the United States, Japan and other countries globally, with a complete list available on astrazeneca.com. Regulatory clearance in the UK is pending and remains a requirement to complete the deal.
- Read more about AstraZeneca receives clearance from the European Commission for the proposed acquisition of Alexion
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/astrazeneca-receives-clearance-from-the-european-commission-for-the-proposed-acquisition-of-alexion
No comments:
Post a Comment